297 related articles for article (PubMed ID: 24714838)
1. Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.
Reis SL; Abdo CH
Clinics (Sao Paulo); 2014; 69(4):294-303. PubMed ID: 24714838
[TBL] [Abstract][Full Text] [Related]
2. [The Role of Testosterone in The Improvement of Sexual Desire in Postmenopausal Women: An Evidence-Based Clinical Review].
Gouveia M; Sanches R; Andrade S; Carmona S; Ferreira C
Acta Med Port; 2018 Nov; 31(11):680-690. PubMed ID: 30521462
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of testosterone in the treatment of hypoactive sexual desire in women: what does the evidence say?].
Espitia De La Hoz FJ
Rev Int Androl; 2023; 21(1):100328. PubMed ID: 36347772
[TBL] [Abstract][Full Text] [Related]
4. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Kingsberg SA; Simon JA; Goldstein I
J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
[TBL] [Abstract][Full Text] [Related]
5. Editorial comments on "the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women".
Goldstein I
J Sex Med; 2008 Sep; 5 Suppl 4():177-8. PubMed ID: 18783531
[No Abstract] [Full Text] [Related]
6. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
[TBL] [Abstract][Full Text] [Related]
7. Testosterone therapy in women: a review.
Bolour S; Braunstein G
Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
[TBL] [Abstract][Full Text] [Related]
9. Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.
Poels S; Bloemers J; van Rooij K; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
J Sex Med; 2013 Mar; 10(3):810-23. PubMed ID: 23130748
[TBL] [Abstract][Full Text] [Related]
10. To be or not to be in sexual desire: the androgen dilemma.
Nappi RE
Climacteric; 2015 Oct; 18(5):672-4. PubMed ID: 26176767
[TBL] [Abstract][Full Text] [Related]
11. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
[TBL] [Abstract][Full Text] [Related]
12. Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder.
Bloemers J; van Rooij K; Poels S; Goldstein I; Everaerd W; Koppeschaar H; Chivers M; Gerritsen J; van Ham D; Olivier B; Tuiten A
J Sex Med; 2013 Mar; 10(3):791-809. PubMed ID: 23130782
[TBL] [Abstract][Full Text] [Related]
13. Methodological Challenges in Studying Testosterone Therapies for Hypoactive Sexual Desire Disorder in Women.
Rowen TS; Davis SR; Parish S; Simon J; Vignozzi L
J Sex Med; 2020 Apr; 17(4):585-594. PubMed ID: 32063470
[TBL] [Abstract][Full Text] [Related]
14. Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder.
Abdallah RT; Simon JA
Int J Impot Res; 2007; 19(5):458-63. PubMed ID: 17581596
[TBL] [Abstract][Full Text] [Related]
15. Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.
van Rooij K; Poels S; Bloemers J; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
J Sex Med; 2013 Mar; 10(3):824-37. PubMed ID: 23130675
[TBL] [Abstract][Full Text] [Related]
16. [Hypoactive sexual desire and testosterone deficiency in men].
Lejeune H; Huyghe É; Droupy S
Prog Urol; 2013 Jul; 23(9):621-8. PubMed ID: 23830256
[TBL] [Abstract][Full Text] [Related]
17. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ; Simon JA; Davis SR; Giraldi A; Goldstein I; Goldstein SW; Kim NN; Kingsberg SA; Morgentaler A; Nappi RE; Park K; Stuenkel CA; Traish AM; Vignozzi L
J Sex Med; 2021 May; 18(5):849-867. PubMed ID: 33814355
[TBL] [Abstract][Full Text] [Related]
18. Clinical Inquiry: which treatments help women with reduced libido?
Hobbs K; Handler L
J Fam Pract; 2013 Feb; 62(2):102-3. PubMed ID: 23405381
[TBL] [Abstract][Full Text] [Related]
19. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Krapf JM; Simon JA
Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
[TBL] [Abstract][Full Text] [Related]
20. Testosterone therapy for sexual dysfunction in men with Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
Algeffari M; Jayasena CN; MacKeith P; Thapar A; Dhillo WS; Oliver N
Diabet Med; 2018 Feb; 35(2):195-202. PubMed ID: 29171080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
